Canavan, M. M. Schilder’s encephalitis periaxialis diffusa: report of a case of a child aged sixteen and one-half months. Arch. Neurol. Psychiatry 25, 299–308 (1931).

Article  Google Scholar 

Leone, P. et al. Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease. Ann. Neurol. 48, 27–38 (2000).

Article  CAS  PubMed  Google Scholar 

Matalon, R., Kaul, R. & Michals, K. Canavan disease: biochemical and molecular studies. J. Inherit. Metab. Dis. 16, 744–752 (1993).

Article  CAS  PubMed  Google Scholar 

Baslow, M. H. Canavan’s spongiform leukodystrophy: a clinical anatomy of a genetic metabolic CNS disease. J. Mol. Neurosci. 15, 61–69 (2000).

Article  CAS  PubMed  Google Scholar 

Francis, J. S. et al. N-Acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase. Neurobiol. Dis. 96, 323–334 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoshino, H. & Kubota, M. Canavan disease: clinical features and recent advances in research. Pediatr. Int. 56, 477–483 (2014).

Article  CAS  PubMed  Google Scholar 

Lotun, A., Gessler, D. J. & Gao, G. Canavan disease as a model for gene therapy-mediated myelin repair. Front. Cell. Neurosci. 15, 661928 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Janson, C. G. et al. Mild-onset presentation of Canavan’s disease associated with novel G212A point mutation in aspartoacylase gene. Ann. Neurol. 59, 428–431 (2006).

Article  CAS  PubMed  Google Scholar 

Velinov, M., Zellers, N., Styles, J. & Wisniewski, K. Homozygosity for mutation G212A of the gene for aspartoacylase is associated with atypical form of Canavan’s disease. Clin. Genet. 73, 288–289 (2008).

Article  CAS  PubMed  Google Scholar 

Adachi, M., Schneck, L., Cara, J. & Volk, B. W. Spongy degeneration of the central nervous system (van Bogaert and Bertrand type; Canavan’s disease). A review. Hum. Pathol. 4, 331–347 (1973).

Article  CAS  PubMed  Google Scholar 

Matalon, R. et al. Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease. Am. J. Med. Genet. 29, 463–471 (1988).

Article  CAS  PubMed  Google Scholar 

Traeger, E. C. & Rapin, I. The clinical course of Canavan disease. Pediatr. Neurol. 18, 207–212 (1998).

Article  CAS  PubMed  Google Scholar 

Bokhari, M. R., Samanta, D. & Bokhari, S. R. A. Canavan Disease (StatPearls Publishing, 2024).

Zelnik, N. et al. Protracted clinical course for patients with Canavan disease. Dev. Med Child Neurol. 35, 355–358 (1993).

Article  CAS  PubMed  Google Scholar 

Zeng, B. J. et al. Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease. J. Inherit. Metab. Dis. 25, 557–570 (2002).

Article  CAS  PubMed  Google Scholar 

Janson, C. et al. Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain. Hum. Gene Ther. 13, 1391–1412 (2002).

Article  CAS  PubMed  Google Scholar 

Leone, P. et al. Long-term follow-up after gene therapy for Canavan disease. Sci. Transl. Med. 4, 165ra3 (2012).

Article  Google Scholar 

Francis, J. S. et al. Preclinical biodistribution, tropism, and efficacy of oligotropic AAV/Olig001 in a mouse model of congenital white matter disease. Mol. Ther. Methods Clin. Dev. 20, 520–534 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Traka, M. et al. Nur7 is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNS. J. Neurosci. 28, 11537–11549 (2008).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hull, V. et al. Antisense oligonucleotide reverses leukodystrophy in Canavan disease mice. Ann. Neurol. 87, 480–485 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maier, H., Wang-Eckhardt, L., Hartmann, D., Gieselmann, V. & Eckhardt, M. N-Acetylaspartate synthase deficiency corrects the myelin phenotype in a Canavan disease mouse model but does not affect survival time. J. Neurosci. 35, 14501–14516 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pleasure, D. et al. Pathophysiology and treatment of Canavan disease. Neurochem. Res. 45, 561–565 (2020).

Article  CAS  PubMed  Google Scholar 

McAllister, A. et al. Quantitative synthetic MRI in children: normative intracranial tissue segmentation values during development. Am. J. Neuroradiol. 38, 2364–2372 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Janson, C. G. et al. Natural history of Canavan disease revealed by proton magnetic resonance spectroscopy (1H-MRS) and diffusion-weighted MRI. Neuropediatrics 37, 209–221 (2006).

Article  CAS  PubMed  Google Scholar 

Mendell, J. R. et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N. Eng. J. Med. 377, 1713–1722 (2017).

Article  CAS  Google Scholar 

Whitley, C. B. et al. Final results of the phase 1/2, open-label clinical study of intravenous recombinant human N-acetyl-α-d-glucosaminidase (SBC-103) in children with mucopolysaccharidosis IIIB. Mol. Genet. Metab. 126, 131–138 (2019).

Article  CAS  PubMed  Google Scholar 

Jakobs, C. et al. Stable isotope dilution analysis of N-acetylaspartic acid in CSF, blood, urine and amniotic fluid: accurate postnatal diagnosis and the potential for prenatal diagnosis of Canavan disease. J. Inherit. Metab. Dis. 14, 653–660 (1991).

Article  CAS  PubMed  Google Scholar 

Kolodziejczyk, K., Hamilton, N. B., Wade, A., Káradóttir, R. & Attwell, D. The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes. Brain 132, 1496–1508 (2009).

Article  PubMed  PubMed Central  Google Scholar 

Corti, M. et al. Adeno-associated virus-mediated gene therapy in a patient with Canavan disease using dual routes of administration and immune modulation. Mol. Ther. Methods Clin. Dev. 30, 303–314 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bley, A. et al. The natural history of Canavan disease: 23 new cases and comparison with patients from literature. Orphanet J. Rare Dis. 16, 227 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Janson, C. G., Romanova, L. G., Rudser, K. D. & Haines, S. J. Improvement in clinical outcomes following optimal targeting of brain ventricular catheters with intraoperative imaging. J. Neurosurg. 120, 684–696 (2014).

Article  PubMed  Google Scholar